The post-COVID outlook for decentralized clinical trials
- DHV-NET

- Feb 20, 2023
- 1 min read
The COVID-19 pandemic had many pharmas turning to DCTs as a way to keep the clinical wheel turning. Can the industry keep that flexibility going forward?




The COVID-19 pandemic had many pharmas turning to DCTs as a way to keep the clinical wheel turning. Can the industry keep that flexibility going forward?
